Norinchukin Bank The raised its position in Express Scripts Holding Company (NASDAQ:ESRX) by 8.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 71,854 shares of the company’s stock after buying an additional 5,733 shares during the quarter. Norinchukin Bank The’s holdings in Express Scripts Holding were worth $4,550,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Teacher Retirement System of Texas boosted its position in shares of Express Scripts Holding by 8.4% in the 1st quarter. Teacher Retirement System of Texas now owns 97,797 shares of the company’s stock worth $6,446,000 after buying an additional 7,562 shares in the last quarter. Financial Counselors Inc. purchased a new stake in shares of Express Scripts Holding in the 1st quarter worth about $223,000. Leucadia National Corp purchased a new stake in shares of Express Scripts Holding in the 1st quarter worth about $462,000. Quaker Capital Investments LLC boosted its position in shares of Express Scripts Holding by 949.5% in the 1st quarter. Quaker Capital Investments LLC now owns 230,072 shares of the company’s stock worth $15,164,000 after buying an additional 208,149 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Express Scripts Holding by 2.3% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 7,002,248 shares of the company’s stock worth $461,517,000 after buying an additional 160,615 shares in the last quarter. 89.34% of the stock is currently owned by institutional investors.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded up $0.93 during mid-day trading on Thursday, hitting $62.12. 3,254,300 shares of the stock traded hands, compared to its average volume of 4,082,135. The stock has a market cap of $34,656.36, a price-to-earnings ratio of 8.95, a P/E/G ratio of 0.90 and a beta of 0.88. Express Scripts Holding Company has a 1-year low of $55.80 and a 1-year high of $77.50. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. The business had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. The company’s revenue was down 2.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.74 EPS. equities analysts expect that Express Scripts Holding Company will post 7.01 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/norinchukin-bank-the-purchases-5733-shares-of-express-scripts-holding-company-esrx/1722030.html.

A number of research firms have issued reports on ESRX. Jefferies Group LLC set a $72.00 target price on shares of Express Scripts Holding and gave the company a “buy” rating in a report on Tuesday, August 29th. Mizuho set a $67.00 target price on shares of Express Scripts Holding and gave the company a “hold” rating in a report on Tuesday, October 24th. Royal Bank Of Canada began coverage on shares of Express Scripts Holding in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 target price on the stock. UBS Group AG lowered shares of Express Scripts Holding from a “market perform” rating to an “underperform” rating in a report on Monday, October 9th. Finally, BidaskClub lowered shares of Express Scripts Holding from a “sell” rating to a “strong sell” rating in a report on Friday, August 4th. Seven investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. Express Scripts Holding currently has a consensus rating of “Hold” and a consensus price target of $69.53.

In other Express Scripts Holding news, CEO Timothy C. Wentworth bought 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 31st. The stock was purchased at an average price of $61.13 per share, with a total value of $489,040.00. Following the transaction, the chief executive officer now owns 98,628 shares in the company, valued at $6,029,129.64. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $63.13, for a total transaction of $36,489.14. Following the sale, the vice president now directly owns 10,530 shares of the company’s stock, valued at approximately $664,758.90. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,121 shares of company stock worth $325,920. Insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.